Position in CUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$218,679
+$170,907 QoQ
Shares Held
6,929
+0.1% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 49 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CUE ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CUE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,679 | 6,929 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $47,772 | 207,708 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $63,307 | 207,569 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $233,330 | 324,521 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $221,366 | 324,584 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $295,483 | 324,351 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $353,503 | 324,315 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $181,075 | 239,202 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $300,784 | 242,568 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $460,433 | 243,616 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $702,838 | 266,227 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $433,945 | 188,672 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $559,096 | 153,177 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $597,957 | 167,495 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $276,546 | 97,034 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $253,130 | 113,512 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $65,512 | 26,311 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $448,475 | 91,901 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,301,439 | 115,070 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $464,445 | 31,877 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $349,977 | 30,041 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $542,130 | 44,437 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $355,621 | 28,427 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $491,186 | 32,637 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $826,893 | 33,737 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $256,611 | 18,084 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||